Margaret G. McGlynn, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 20,000 shares at $190.00 ($3.8M) on 2019-10-22, disclosed to the SEC on 2019-10-24.
Open-market sale of $3.8M VRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FOLD | SELL | 2022-05-04 | $105K | — | Filing → |
| VRTX | SELL | 2022-04-12 | $1.4M | — | Filing → |
| VRTX | SELL | 2022-04-04 | $2.6M | — | Filing → |